Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone versus dexamethasone bioequivalence crossover study
NL-OMON50073Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of prednisolone and dexamethasone (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Bioequivalence at lower and higher dose by HPA-axis suppression. Started Mar 2021; status: active, not recruiting.
02
Drugs
prednisolonedexamethasone
Beyond the preview
Go deeper on NL-OMON50073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50073.